BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38301513)

  • 21. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paediatric ocular adnexal lymphoma: a population-based analysis.
    Moustafa GA; Topham AK; Aronow ME; Vavvas DG
    BMJ Open Ophthalmol; 2020; 5(1):e000483. PubMed ID: 32596505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bag-of-features-based radiomics for differentiation of ocular adnexal lymphoma and idiopathic orbital inflammation from contrast-enhanced MRI.
    Hou Y; Xie X; Chen J; Lv P; Jiang S; He X; Yang L; Zhao F
    Eur Radiol; 2021 Jan; 31(1):24-33. PubMed ID: 32789530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study.
    Yang X; Wang R; Yuan X; Yao S; Wang C; Cheng J
    Radiat Oncol; 2022 Dec; 17(1):208. PubMed ID: 36539787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma.
    Rath S; Connors JM; Dolman PJ; Rootman J; Rootman DB; White VA
    Orbit; 2014 Feb; 33(1):23-8. PubMed ID: 24180616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and treatment outcomes of secondary ocular adnexal lymphoma.
    Yang Y; Jin X; Wang Y; Ma R; He W
    Clin Exp Ophthalmol; 2023 Mar; 51(2):154-161. PubMed ID: 36326836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
    Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
    Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular adnexal lymphoma classified using the WHO classification: not only histology and stage, but also gender is a predictor of outcome.
    Plaisier MB; Sie-Go DM; Berendschot TT; Petersen EJ; Mourits MP
    Orbit; 2007 Jun; 26(2):83-8. PubMed ID: 17613853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic value of
    Harada N; Kondo K; Terazono S; Uchino K; Fuchinoue Y; Sugo N
    Int Ophthalmol; 2022 Apr; 42(4):1205-1212. PubMed ID: 34725770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.
    Yoo C; Ryu MH; Huh J; Park JH; Kang HJ; Ahn HS; Lee Y; Kim MJ; Lee H; Kim TW; Chang HM; Lee JL; Kang YK
    Am J Hematol; 2007 Sep; 82(9):821-3. PubMed ID: 17570512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
    Sagiv O; Thakar SD; Manning JT; Kandl TJ; Fayad LE; Fowler N; Hagemeister FB; Fanale MA; Pinnix CC; Samaniego F; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):243-246. PubMed ID: 30124609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
    Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma.
    Travaglino A; Pace M; Varricchio S; Russo D; Pugliese N; Severino A; Picardi M; Pane F; Insabato L; Staibano S; Mascolo M
    Pathol Oncol Res; 2020 Oct; 26(4):2075-2081. PubMed ID: 32557170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival.
    Rootman DB; Mavrikakis I; Connors JM; Rootman J
    Ophthalmic Plast Reconstr Surg; 2011; 27(6):405-9. PubMed ID: 21659919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
    Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
    Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on ocular adnexal lymphoma.
    Mulay K; Honavar SG
    Semin Diagn Pathol; 2016 May; 33(3):164-72. PubMed ID: 26972223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori Infection of the Gastric Mucosa and Ocular Adnexa-Lack of Association With Ocular Adnexal Lymphoma.
    Kalin-Hajdu E; Bernier-Turmel F; Frost É; Labbé AC; Couture S; Wong J; Boulos PR; Codère F; Hardy I
    Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S1-S5. PubMed ID: 32932407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.
    Ferreri AJ; Ponzoni M; Guidoboni M; Resti AG; Politi LS; Cortelazzo S; Demeter J; Zallio F; Palmas A; Muti G; Dognini GP; Pasini E; Lettini AA; Sacchetti F; De Conciliis C; Doglioni C; Dolcetti R
    J Natl Cancer Inst; 2006 Oct; 98(19):1375-82. PubMed ID: 17018784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
    Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
    Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.